Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
5
×
cancer immunotherapy
5
×
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
investing
life sciences
5
×
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
5
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
fda
alexion pharmaceuticals
alzheimer's disease
biogen
bristol-myers squibb
clinical trials
What
bio
roundup
drug
alzheimer’s
companies
growing
pharmaceutical
prices
typically
alliance
annual
approved
assessed
attention
bails
biotech
brand
bridgebio
bristol
buy
calls
capital
car
changing
color
communities
conference
crispr
days
develop
different
digital
disease
drugs
emerges
epidemic
esmo
europe
fail
fatty
Language
unset
Current search:
cancer
×
startups
×
" cancer immunotherapy "
×
pfizer
×
" life sciences "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More